Mixed reality moves into the enterprise mainstream

Tern plc

A new phase of computing is taking shape as artificial intelligence and mixed reality converge. The shift from virtual to spatial computing marks the point where digital content no longer replaces reality but enhances it, and this time the technology is ready to scale.

Over the past ten years, immersive devices have moved through several hype cycles. Oculus, Vive, and Meta each pushed boundaries, but adoption stalled outside specialist sectors. Apple changed that dynamic with the launch of Vision Pro, positioning mixed reality as a serious computing platform rather than an entertainment accessory.

In parallel, AI has embedded itself across business software, creating intelligent systems that learn, predict, and respond to human needs. The merging of these two technologies is transformative. Mixed reality now has access to real-time understanding through AI, allowing devices to see, hear, and act on context. As hardware becomes lighter and socially acceptable, mixed reality glasses are set to evolve into all-day wearables that deliver live guidance, data access, and communication.

Meta’s display glasses with gesture control, Samsung and Google’s Moohan headset with Gemini AI, Amazon’s Jayhawk smart glasses for employees, and Apple’s Vision Air all signal a shared destination. By 2028, these devices will move into everyday enterprise use.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc reports 2025 results and outlines portfolio value strategy

Tern plc has reported audited annual results, outlined portfolio developments and convened a General Meeting for 9 July 2026.

Device Authority targets enterprise IoT security demand through Xalient partnership

Device Authority has partnered with Xalient to bring KeyScaler into managed enterprise security services, strengthening its position in scalable IoT and OT device identity management.

Talking Medicines targets a clearer view of GLP-1 and cancer care demand

Talking Medicines is showing why real-world healthcare conversations matter for investors tracking GLP-1, oncology and the next stage of life sciences market positioning.

GLP-1 cancer signals add a new investor angle

Early oncology signals from ASCO 2026 add a new investor angle to the GLP-1 story, with further research needed before clinical or commercial conclusions can be drawn.

Device Authority expands enterprise reach through IoT security partnership

Device Authority’s partnership with Xalient strengthens its enterprise IoT security positioning as regulated industries look for scalable, automated ways to manage connected device risk.

Pharma engagement shifts from reach to relevance

Pharma engagement is moving from broad reach to relevant messaging across connected patient journeys.

Search